MedPath
TGA Approval

STRENSIQ asfotase alfa rch 40 mg/1.00 ml solution for injection vial (232546)

232546

STRENSIQ asfotase alfa rch 40 mg/1.00 ml solution for injection vial

Alexion Pharmaceuticals Australasia Pty Ltd

January 14, 2016

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/d9981266161e485c8f809f8c328887f5.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/07c086777fbaf3e6eb13f7cff916de7a.pdf

Active Ingredients

asfotase alfa

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

STRENSIQ asfotase alfa rch 40 mg/1.00 ml solution for injection vial (232546) - TGA 批准文号 | MedPath